Janet has over 20 years of experience in a variety of Life Sciences organisations: a University start-up; Oxford University; an independent research organisation; Novartis Pharmaceuticals; Vertex Pharmaceuticals, and her own company.  Janet is passionate about the life sciences sector and has a deep understanding of the process that turns a scientific idea a commercial reality. Having worked abroad in Switzerland, Germany, France, and Cuba, Janet has considerable cultural awareness. As a result of managing complex, drug R&D projects, and mentoring start-ups, she also has great project management skills and a love of problem solving.  

Key areas of expertise include:

• Buyer-supplier relationships in the pharma industry 
• Strategic portfolio management
• Risk management in drug discovery
• Business planning and financial modelling
• IT skills including MS Project Server and SharePoint
• Regulatory requirements for phase I oncology drug trials 

Qualifications and Awards

• BSc (Hons) Biochemistry, University of Bath
• PhD Medicine, University of Bristol
• MBA, University of Bath
• APM Project Management qualification
  

Sector/Project Experience Includes:

• Change management at a small pharmaceutical company for the transition to Microsoft suite of IT tools. Trained staff on the new tools.
• Built and maintained Project SharePoint sites.
• Phase I oncology clinical trial preparation. Author of the protocol, CRFs, IB, IMPD, CTA and ethics application for a trial, comprising two licensed drugs, one novel IMP and radiotherapy.
• Responsible for budget, grant applications, and GMP certification.
• Built the implementation team, presented the trial to key opinion leaders for feedback and involved patients in trial design.
• Project management of oncology programmes as they transitioned from discovery to development. Owned timelines, monitored and communicated progress against plans and risks.
• Regulatory support Responsible for review of phase I oncology FDA study reports to ensure fit for purpose.
• Risk analysis and management of research programmes as part of strategic portfolio review.